Literature DB >> 33564683

Comparison of Immune Response between SARS, MERS, and COVID-19 Infection, Perspective on Vaccine Design and Development.

Hossein Ansariniya1, Seyed Mohammad Seifati2, Erfan Zaker3, Fateme Zare2,4.   

Abstract

Severe Acute Respiratory Syndrome (SARS), Middle East Respiratory Syndrome (MERS), and Coronavirus Disease 2019 (COVID-19) infections are the three epidemiological diseases caused by the Coronaviridae family. Perceiving the immune responses in these infections and the escape of viruses could help us design drugs and vaccines for confronting these infections. This review investigates the innate and adaptive immune responses reported in the infections of the three coronaviruses SARS, MERS, and COVID-19. Moreover, the present study can trigger researchers to design and develop new vaccines and drugs based on immune system responses. In conclusion, due to the need for an effective and efficient immune stimulation against coronavirus, a combination of several strategies seems necessary for developing the vaccine.
Copyright © 2021 Hossein Ansariniya et al.

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33564683      PMCID： PMC7841448          DOI： 10.1155/2021/8870425

Source DB:  PubMed          Journal:  Biomed Res Int            Impact factor:   3.411


  82 in total

1.  Characterization of cytokine/chemokine profiles of severe acute respiratory syndrome.

Authors:  Yong Jiang; Jun Xu; Chengzhi Zhou; Zhenguo Wu; Shuqing Zhong; Jinghua Liu; Wei Luo; Tao Chen; Qinghe Qin; Peng Deng
Journal:  Am J Respir Crit Care Med       Date:  2005-01-18       Impact factor: 21.405

2.  Severe acute respiratory syndrome and the innate immune responses: modulation of effector cell function without productive infection.

Authors:  Chien-Te K Tseng; Lucy A Perrone; Hongbing Zhu; Shinji Makino; Clarence J Peters
Journal:  J Immunol       Date:  2005-06-15       Impact factor: 5.422

Review 3.  Review of bats and SARS.

Authors:  Lin-Fa Wang; Zhengli Shi; Shuyi Zhang; Hume Field; Peter Daszak; Bryan T Eaton
Journal:  Emerg Infect Dis       Date:  2006-12       Impact factor: 6.883

Review 4.  The biological function and clinical utilization of CD147 in human diseases: a review of the current scientific literature.

Authors:  Lijuan Xiong; Carl K Edwards; Lijun Zhou
Journal:  Int J Mol Sci       Date:  2014-09-29       Impact factor: 5.923

Review 5.  Middle East respiratory syndrome and severe acute respiratory syndrome.

Authors:  Rahul Vijay; Stanley Perlman
Journal:  Curr Opin Virol       Date:  2016-02-12       Impact factor: 7.090

6.  Immune Responses to Middle East Respiratory Syndrome Coronavirus During the Acute and Convalescent Phases of Human Infection.

Authors:  Hyoung-Shik Shin; Yeonjae Kim; Gayeon Kim; Ji Yeon Lee; Ina Jeong; Joon-Sung Joh; Hana Kim; Eunjin Chang; Soo Yeon Sim; Jun-Sun Park; Dong-Gyun Lim
Journal:  Clin Infect Dis       Date:  2019-03-05       Impact factor: 9.079

7.  Middle East Respiratory Syndrome Coronavirus Efficiently Infects Human Primary T Lymphocytes and Activates the Extrinsic and Intrinsic Apoptosis Pathways.

Authors:  Hin Chu; Jie Zhou; Bosco Ho-Yin Wong; Cun Li; Jasper Fuk-Woo Chan; Zhong-Shan Cheng; Dong Yang; Dong Wang; Andrew Chak-Yiu Lee; Chuangen Li; Man-Lung Yeung; Jian-Piao Cai; Ivy Hau-Yee Chan; Wai-Kuen Ho; Kelvin Kai-Wang To; Bo-Jian Zheng; Yanfeng Yao; Chuan Qin; Kwok-Yung Yuen
Journal:  J Infect Dis       Date:  2015-07-22       Impact factor: 5.226

8.  A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster.

Authors:  Jasper Fuk-Woo Chan; Shuofeng Yuan; Kin-Hang Kok; Kelvin Kai-Wang To; Hin Chu; Jin Yang; Fanfan Xing; Jieling Liu; Cyril Chik-Yan Yip; Rosana Wing-Shan Poon; Hoi-Wah Tsoi; Simon Kam-Fai Lo; Kwok-Hung Chan; Vincent Kwok-Man Poon; Wan-Mui Chan; Jonathan Daniel Ip; Jian-Piao Cai; Vincent Chi-Chung Cheng; Honglin Chen; Christopher Kim-Ming Hui; Kwok-Yung Yuen
Journal:  Lancet       Date:  2020-01-24       Impact factor: 79.321

9.  Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants.

Authors:  Yiska Weisblum; Fabian Schmidt; Fengwen Zhang; Justin DaSilva; Daniel Poston; Julio Cc Lorenzi; Frauke Muecksch; Magdalena Rutkowska; Hans-Heinrich Hoffmann; Eleftherios Michailidis; Christian Gaebler; Marianna Agudelo; Alice Cho; Zijun Wang; Anna Gazumyan; Melissa Cipolla; Larry Luchsinger; Christopher D Hillyer; Marina Caskey; Davide F Robbiani; Charles M Rice; Michel C Nussenzweig; Theodora Hatziioannou; Paul D Bieniasz
Journal:  Elife       Date:  2020-10-28       Impact factor: 8.140

Review 10.  DCs-based therapies: potential strategies in severe SARS-CoV-2 infection.

Authors:  Jian Han; Jiazhi Sun; Guixin Zhang; Hailong Chen
Journal:  Int J Med Sci       Date:  2021-01-01       Impact factor: 3.738
View more
  7 in total

Review 1.  Neuropathological Aspects of SARS-CoV-2 Infection: Significance for Both Alzheimer's and Parkinson's Disease.

Authors:  Jaime Silva; Felipe Patricio; Aleidy Patricio-Martínez; Gerardo Santos-López; Lilia Cedillo; Yousef Tizabi; Ilhuicamina Daniel Limón
Journal:  Front Neurosci       Date:  2022-05-03       Impact factor: 5.152

2.  Early Cellular and Humoral Responses Developed in Oncohematological Patients after Vaccination with One Dose against COVID-19.

Authors:  Sara Rodríguez-Mora; Magdalena Corona; Montserrat Torres; Guiomar Casado-Fernández; Javier García-Pérez; Fernando Ramos-Martín; Lorena Vigón; Mario Manzanares; Elena Mateos; Fernando Martín-Moro; Alejandro Zurdo-Castronuño; María Aranzazu Murciano-Antón; José Alcamí; Mayte Pérez-Olmeda; Javier López-Jiménez; Valentín García-Gutiérrez; Mayte Coiras
Journal:  J Clin Med       Date:  2022-05-16       Impact factor: 4.964

Review 3.  A review on the immune responses against novel emerging coronavirus (SARS-CoV-2).

Authors:  Ramin Lotfi; Rasoul Nasiri Kalmarzi; Seyed Askar Roghani
Journal:  Immunol Res       Date:  2021-04-29       Impact factor: 4.505

4.  Oral Administration of Coronavirus Spike Protein Provides Protection to Newborn Pigs When Challenged with PEDV.

Authors:  Magdalena Maj; Gina M Fake; John H Walker; Ryan Saltzman; John A Howard
Journal:  Vaccines (Basel)       Date:  2021-11-30

5.  Potential Cross-Reactive Immunity to COVID-19 Infection in Individuals With Laboratory-Confirmed MERS-CoV Infection: A National Retrospective Cohort Study From Saudi Arabia.

Authors:  Anas A Khan; Ahmed A Alahmari; Yasir Almuzaini; Fahad Alamri; Yousef Mohammad Alsofayan; Alhanouf Aburas; Saleh Al-Muhsen; Maria Van Kerkhove; Saber Yezli; Gregory R Ciottone; Abdullah M Assiri; Hani A Jokhdar
Journal:  Front Immunol       Date:  2021-09-17       Impact factor: 7.561

Review 6.  A review of the effect of COVID-19 on immune responses of the body.

Authors:  Yasaman Hekmatnia; Faeze Rahmani; Zohreh Feili; Farnoosh Ebrahimzadeh
Journal:  J Family Med Prim Care       Date:  2022-05-14

7.  Impaired Cytotoxic Response in PBMCs From Patients With COVID-19 Admitted to the ICU: Biomarkers to Predict Disease Severity.

Authors:  Lorena Vigón; Daniel Fuertes; Javier García-Pérez; Montserrat Torres; Sara Rodríguez-Mora; Elena Mateos; Magdalena Corona; Adolfo J Saez-Marín; Rosa Malo; Cristina Navarro; María Aranzazu Murciano-Antón; Miguel Cervero; José Alcamí; Valentín García-Gutiérrez; Vicente Planelles; María Rosa López-Huertas; Mayte Coiras
Journal:  Front Immunol       Date:  2021-05-26       Impact factor: 7.561
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.